[Federal Register Volume 73, Number 116 (Monday, June 16, 2008)]
[Notices]
[Page 34023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-13491]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a 
Gestational Diabetes-Affected Pregnancy, Potential Extramural Project 
(PEP) 2008-R-02

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time And Date: 1 p.m.-3 p.m., June 18, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463. This notice 
was published in the Federal Register on April 16, 2008, Volume 73, 
Number 74, page 20677. Additional time is required to complete the 
review of all applications submitted for this PEP. Applications 
being reviewed at the June 18, 2008, meeting will be reviewed by the 
same members of the original panel.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Improving Postpartum Follow up in 
Women with a Gestational Diabetes-Affected Pregnancy, PEP 2008-R-
02.''
    The National Center for Health Marketing determines that agency 
business requires its consideration of this matter on less than 15 
days' notice to the public and that no earlier notice of this 
meeting was possible.
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-13491 Filed 6-13-08; 8:45 am]
BILLING CODE 4163-18-P